ConductScience.org, home
Cell lines
API referenceFor AI assistants

Cell line · CVCL_1051

786-O

Cancer cell line, Homo sapiens. Renal cell carcinoma. 166 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. 786-O. Cell lines, record CVCL_1051. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1051

On this page

Cell line

As Cellosaurus gives it.

Name
786-O
Accession
CVCL_1051
RRID
RRID:CVCL_1051
Synonyms
786-o, 786O, 786-0, 786.O, 786-O RCC, RCC 786-O, RCC_7860, RCC 7860, 7860, 786-0WT
Species
Homo sapiens (Human)
Sex
Male
Age at sampling
58Y
Category
Cancer cell line
Diseases
Renal cell carcinoma (NCIt C9385); Renal cell carcinoma (ORDO Orphanet_217071)
Derived from
Kidney (in situ)
Entry created
2012-04-04
Entry updated
2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers166

2 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.

PaperJournalYearHow we knowRetractedSource
Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers.Mol Oncol2026Its Methods give the RRID and name the linePubMed
Inhibition of PLK1 helps to restrict c-Met-induced growth and therapeutic resistance of renal cancer cells.Mol Cancer Ther2026Its Methods give the RRID and name the linePubMed
Reduced VEPH1 expression is associated with an invasive phenotype and poor prognosis in clear cell renal cell carcinoma.Transl Androl Urol2026Its Methods give the RRID and name the linePubMed
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.Clin Cancer Res2026Its Methods give the RRID and name the linePubMed
Tumor-Induced PDPN+ Lymphatic-like Endothelial Cells Promote Clear-Cell Renal Cell Carcinoma Progression Through Reciprocal BMP10-CXCL13 Signaling.Int J Mol Sci2026Its Methods give the RRID and name the linePubMed
Lysyl oxidase drives ccRCC progression by coordinating HIF-2α transcription program with tumor microenvironment.bioRxiv2026Its Methods give the RRID and name the linePubMed
RIOK2 Promotes Clear Cell Renal Cell Carcinoma Progression Through Cell Cycle Regulation.Cancer Med2026Its Methods give the RRID and name the linePubMed
Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and In Vitro Verification.Cancer Med2026Its Methods give the RRID and name the linePubMed
ALYREF-mediated m5C modification of CCNA1 drives escape from cell-cycle arrest and contributes to pazopanib resistance in Renal Cell Carcinoma.Int J Biol Sci2026Its Methods give the RRID and name the linePubMed
Engineered iMSCs delivering wild-type IL-2 achieve dose-sparing tumor control via CD25-dependent CD8+ T-cell activation.BMC Med2026Its Methods give the RRID and name the linePubMed

1 to 10 of 166

See all 166 papers

Relatives35

RelationCell lineAccessionProblemSource
Derived from it786-M1ACVCL_VR30Cell lines
Derived from it786-M1BCVCL_VR31Cell lines
Derived from it786-O PBRM1 KO 1CVCL_E3VJCell lines
Derived from it786-O PBRM1 KO 2CVCL_E3VKCell lines
Derived from it786-O PBRM1 KO 3CVCL_E3VLCell lines
Derived from it786-O PBRM1 KO 4CVCL_E3VMCell lines
Derived from it786-O SAV1 clone 1CVCL_D6UUCell lines
Derived from it786-O SAV1 clone 2CVCL_D6UVCell lines
Derived from it786-O-Luc [JCRB]CVCL_J240Cell lines
Derived from it786-O-Luc [Ubigene]CVCL_C8WUCell lines

1 to 10 of 35

See all 35 relatives

Cell banks9

Cell bankCatalog numberStatusSource
ATCCCRL-1932ATCC
BCRC60243BCRC
CCTCCGDC0159Cellosaurus
CLS300107CLS
EDITGENEEDC00245EDITGENE
IZSLERBS TCL 124Cellosaurus
KCBKCB 200941YJCellosaurus
NCI-DCTD786-0Cellosaurus
UbigeneYC-C113Ubigene

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_1051

GET https://conductscience.org/api/cell-lines/v1/CVCL_1051/papers?page=2

API referenceFor AI assistants